Trial intelligence / Profile preview

LIFT: Biomarker-guided IS Withdrawal in Liver Transplant

NCT02498977Phase 4Terminated

Sponsor
King's College London
Start
Oct 2015
Primary completion
Dec 2021
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in liver transplantation, sponsored by King's College London. Primary endpoint: Successful discontinuation of IS with maintenance of normal allograft status at 12 months. Started Oct 2015; status: terminated.

02

Conditions

liver transplantation

Beyond the preview

Go deeper on NCT02498977.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02498977.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call